Last reviewed · How we verify

NCT03922165: HELP-DS

Healthy Sleep for Children With Down Syndrome

Completed Last updated 2 March 2022
What this trial tests

trial testing Adenotonsillectomy in Down Syndrome in 26 participants. Completed in 31 December 2021.

Timeline
22 May 2019
Primary endpoint
20 December 2021
31 December 2021

Quick facts

Lead sponsorBrigham and Women's Hospital
StatusCompleted
Study typeOBSERVATIONAL
Enrollment26
Start date22 May 2019
Primary completion20 December 2021
Estimated completion31 December 2021
Sites6 locations across United States

Drugs / interventions tested

Conditions studied

Sponsor

Brigham and Women's Hospital

Who can join

Adults 3 to 13, any sex, with Down Syndrome or Sleep Disordered Breathing. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The purpose of this multi-center observational study (utilizing the sites enrolling patients for the Pediatric Adenotonsillectomy Trial for Snoring (PATS) \[1U011HL125307-O1A1\]) is to gather data regarding children with Down syndrome (DS) and Sleep Disordered Breathing (SDB) referred for treatment with adenotonsillectomy to inform a future randomized controlled trial in this population.

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other trials of Adenotonsillectomy

Trials testing the same drug.

Other recruiting trials for Down Syndrome

Currently open trials in the same condition.

Other Brigham and Women's Hospital trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03922165.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing